The Study Of NN Insulin Marketing Strategy In Shijiazhuang Regional Market

In recent years,along with the development of chinese economic people's life style is changing.The incidence of diabetes increased year by year,the number of people with diabetes in China has more than 100 million.But Chinese diabetes treatment status is not ideal,with a low awareness rate,low diagnosis rate,low treatment rate and low success rate.Chinese government pay attention to diabetes is one of the most important diseases of chronic disease management.In Shijiazhuang market there has three transnational corporation:NN,Lilly and Sanofi-Aventis,and two local companies: Tonghua Dongbao Group,Gan&Li.NN is a Denmark companye,founded in 90 years,committed to the development and promotion of diabetes drugs—insulin,has the most complete insulin product line and the most professional drug R&D.In1994 NN came in China.And have done a variety of educational activities to promote insulin.NN has good corporate image,it's products has the confidence of patients' and medical staff's.The market share is much higher than its competitors.Market gorwth has led to more interprise to participate.NN's market share continues to decline.For the study of different insulin product positioning,the Shijiazhuang regional market policy environment,economic environment,consumer characteristics,competitive environment and other aspects of a detailed study and analysis for the and improvement measures,to make Shijiazhuang regional marketing strategy and hope to provide a reference for other areas of China.